A French biotech has raised €12m to test whether GLP-1 drugs can modify osteoarthritis progression. The funding will advance 4Moving Biotech’s lead programme, 4P004, toward a...
An EEG test can identify dementia risk five to seven years before progression to mild cognitive impairment or Alzheimer’s dementia, new research suggests. Using EEG data,...
Harbor Health has acquired dementia care startup Rippl; terms were not disclosed. Founded in 2021, Rippl provides specialised dementia care and support, including personalised care plans,...
The Scottish Medicines Consortium has declined to recommend the Alzheimer’s therapy donanemab (Kisunla, Eli Lilly) for early-stage disease in NHS Scotland. The decision affects patients with...
Harnessing the multi-dimensional capabilities of the human body is key to overcoming chronic pain and boosting longevity, say the authors of a new book. While the...
Longevity startup Biopeak has secured US$2.7m in a follow-on funding round. Founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak operates India’s first specialised brand...
People are twice as likely to inherit their lifespan as previously thought, new research suggests. The genetic contribution to how long a person lives is around...
Biotechnology company Aerska has raised US$39m in Series A funding to develop brain-delivered RNA medicines. The company is developing treatments for neurological diseases, including genetically driven...
Novo Nordisk will launch an Ozempic pill for diabetes in select doses in the second quarter of this year. The Danish drugmaker said the US Food...
Limiting the PTP1B enzyme could slow memory loss in Alzheimer’s, pointing to a potential treatment route, new research suggests. The enzyme appears to contribute to memory...
